Filing Details
- Accession Number:
- 0001562180-17-003253
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-12 16:24:54
- Reporting Period:
- 2017-10-10
- Accepted Time:
- 2017-10-12 16:24:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
842023 | Bio-Techne Corp | TECH | Biological Products, (No Disgnostic Substances) (2836) | 411427402 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
902080 | C Roger Lucas | 41 East Pleasant Lake Road North Oaks MN 55127 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-10-10 | 100 | $121.96 | 1,870 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $101.19 | 2026-10-26 | 3,985 | 3,985 | Direct | |
Common Stock | Stock Option (right to buy) | $91.78 | 2014-10-30 | 2024-10-30 | 4,000 | 4,000 | Direct |
Common Stock | Stock Option (right to buy) | $87.39 | 2013-10-31 | 2023-10-30 | 4,000 | 4,000 | Direct |
Common Stock | Stock Option (right to buy) | $87.34 | 2016-10-29 | 2025-10-28 | 4,260 | 4,260 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2026-10-26 | 3,985 | 3,985 | Direct |
2024-10-30 | 4,000 | 4,000 | Direct |
2023-10-30 | 4,000 | 4,000 | Direct |
2025-10-28 | 4,260 | 4,260 | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 1, 2016.
- The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.